Correlation Between Lixte Biotechnology and Panbela Therapeutics

Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Panbela Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Panbela Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lixte Biotechnology Holdings and Panbela Therapeutics, you can compare the effects of market volatilities on Lixte Biotechnology and Panbela Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Panbela Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Panbela Therapeutics.

Diversification Opportunities for Lixte Biotechnology and Panbela Therapeutics

0.17

Correlation Coefficient

Lixte Biotechnology  Panbela Therapeutics

Average diversification

The 3 months correlation between Lixte and Panbela is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Panbela Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Panbela Therapeutics and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Panbela Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Panbela Therapeutics has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Panbela Therapeutics go up and down completely randomly.

Pair Corralation between Lixte Biotechnology and Panbela Therapeutics

If you would invest  199.00  in Lixte Biotechnology Holdings on September 13, 2024 and sell it today you would lose (4.00) from holding Lixte Biotechnology Holdings or give up 2.01% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

Lixte Biotechnology Holdings  vs.  Panbela Therapeutics

Lixte Biotechnology

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lixte Biotechnology Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Lixte Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Panbela Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Panbela Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Panbela Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Lixte Biotechnology and Panbela Therapeutics

The main advantage of trading using opposite Lixte Biotechnology and Panbela Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Panbela Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Panbela Therapeutics will offset losses from the drop in Panbela Therapeutics' long position.

The idea behind Lixte Biotechnology Holdings and Panbela Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.